Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Migraine prevention with low-dose blood pressure lowering and statin-based therapy
ACTRN12616000937415Phase 4Terminated
- Sponsor
- The George Institute for Global Health
- Start
- Mar 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of telmisartan, amlodipine, indapamide, propranolol, rosuvastatin and 2 more in migraine, sponsored by The George Institute for Global Health. Primary endpoint: Change from baseline in mean monthly migraine headache days. Started Mar 2017; status: terminated.
02
Drugs
telmisartanamlodipineindapamidepropranololrosuvastatin
03
Conditions
migraine
Beyond the preview
Go deeper on ACTRN12616000937415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000937415.